Specialties
Cartilage
Specialties
Orthopaedics
133 results found in 3ms
ChondroFiller injection for knee cartilage defectsChondroFiller injection for knee cartilage defects
The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.The injected collagen scaffold gels in place and recruits the body's own progenitor cells to repair the cartilage defect without surgery or general anaesthetic. Functional scores improve from 48 to 80 on the IKDC scale over three years in independent European cohorts, with most of that improvement within six months.
What separates ChondroFiller from Liquid CartilageWhat separates ChondroFiller from Liquid Cartilage
ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.ChondroFiller is a single collagen scaffold delivered two ways: as an outpatient injection alone, or combined with patient-derived cells under the clinical brand Liquid Cartilage™. Naming overlap at clinics obscures which is being offered.
ChondroFiller injection safety and the questions to askChondroFiller injection safety and the questions to ask
ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.ChondroFiller shows a near-zero complication rate across published trials and over 19,000 post-market cases; fibrous tissue forms only when the scaffold is overfilled, making precise dose determination from pre-procedure MRI the key safeguard.
ChondroFiller NHS status and private access routesChondroFiller NHS status and private access routes
ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.ChondroFiller is not available on the NHS, pending formal health technology assessment; private, self-funded treatment is the sole current UK access route.
What IKDC and MOCART scores mean after ChondroFillerWhat IKDC and MOCART scores mean after ChondroFiller
IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.IKDC scores typically improve by about 30 points after ChondroFiller—roughly double the clinically meaningful threshold—translating to pain-free walking, stair management, and low-moderate recreational return within a year.
ChondroFiller injection for ankle cartilage defectsChondroFiller injection for ankle cartilage defects
ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.ChondroFiller is an acellular collagen scaffold that fills talar cartilage defects without tissue harvest or surgery: it gels within the lesion and recruits the patient's own progenitor cells to drive repair. Delivered under ultrasound guidance as an outpatient procedure, it requires no general anaesthetic or theatre admission.
ChondroFiller for focal knee defects versus early osteoarthritisChondroFiller for focal knee defects versus early osteoarthritis
Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.Focal cartilage defects and early osteoarthritis produce identical symptoms but differ structurally — a contained lesion versus compartment-wide degeneration — and imaging determines which pathway applies. ChondroFiller, an injectable collagen scaffold into which the body's progenitor cells migrate and lay down new cartilage tissue, addresses only focal lesions.
Choosing a ChondroFiller injection providerChoosing a ChondroFiller injection provider
ChondroFiller's collagen scaffold gels within minutes; accurate positioning demands real-time ultrasound guidance, and candidacy assessment requires pre-treatment MRI review.ChondroFiller's collagen scaffold gels within minutes; accurate positioning demands real-time ultrasound guidance, and candidacy assessment requires pre-treatment MRI review.
ACI for Ankle Cartilage DefectsACI for Ankle Cartilage Defects
Microfracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.Microfracture produces fibrocartilage that deteriorates within two to three years for ankle cartilage lesions over 15 mm in diameter; autologous chondrocyte implantation regenerates more durable, hyaline-like cartilage that more closely resembles native tissue for larger defects.
ChondroFiller injection costs in the UK and EuropeChondroFiller injection costs in the UK and Europe
ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.ChondroFiller costs £3,000–£8,000 in the UK, scaled by defect size, delivered as an ultrasound-guided outpatient injection with no surgery or anaesthetic.
ChondroFiller for Shoulder Cartilage DefectsChondroFiller for Shoulder Cartilage Defects
Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.Focal shoulder cartilage defects are now treatable with a single ultrasound-guided collagen injection that recruits the body's own repair cells, forming hyaline-like tissue over 12 months without surgery or general anaesthetic.
ChondroFiller injection safety: what the evidence showsChondroFiller injection safety: what the evidence shows
Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).Over 19,000 ChondroFiller injections have been administered globally with no serious adverse effects reported; reoperation rates of 3–8% fall well below surgical alternatives such as microfracture (up to 41%) and ACI/MACI (up to 37%).
133 results found in 3ms